Dynamics of hemorheology indicators in patients with chronic limbischemia as a result of angiogenesis stimulation

Authors: L.A. Bockeria, M.V. Eremeeva, N.N. Samsonova, V.S. Arakelyan, O.A. Demidova

Company: A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Russian Academy of Medical Sciences


For citation: Bockeria LA, Eremeeva MV, Samsonova NN, at al. Dynamics of hemorheology indicators in patients with chronic limb ischemia as a result of angiogenesis stimulation. Kreativnaya kardiologiya. 2013; 1: 66-73 (in Russian).

Keywords: chronic lower limb ischemia angiogenesis stimulant hemorheology microcirculation

Полнотекстовая версия:  

 

Abstract

Objective. To analyse the hemorheology indicators in patients with chronic limb ischemia after administration of angiogenesis stimulants.

Material and methods. The research was open, non-randomized, in one center. 66 patients were included in the study, patients aged 30 to 77 years (mean age 58.2±12.1 years). 61 patients were presented with atherosclerotic lesion of arteries of lower extremities, 5 patients with thromboangiitis obliterans. Angiogenesis stimulant bolus was administered for all patients. Autologous cells i.e. precursors of endothelioblasts CD 133+ were injected to patients of the 1st group (17 patients), genetic medicament of the vascular endothelial growth factor VEGF165 was injected in the 2nd group (49 patients). During the whole follow-up period the patients received basic antiplatelet therapy. Medicaments and their dosage were selected initially and remained unchanged since the trial commencement.

Results.
All patients examined 1, 3 and 6 months after have reported the clinical improvement as well as according to the instrumental diagnostic methods. The improvement of hemorheologic indicators was recorded already 1 month later, microcirculation indicators 3 months after angiogenesis stimulant injection.

Conclusion.
Changes of hemorheology indicators have represented the microcirculation changes.

References

1. Савельев В.С., Кошкин В.М. Критическая ишемия нижних конечностей. М.: Медицина; 1997: 160. 2. Лазаренко В.Л., Симоненков А.Б., Лазарев Е.В. Лечение критической ишемии нижних конечностей с использованием серотонина. Ангиология и сосудистая хирургия. 2003: 2: 26–30. 3. Бурлева Е.П. Критическая ишемия нижних конечностей: современные клинические и управленческие подходы: дис. … д-ра мед. наук. М.; 2003. 4. Бокерия Л.А., Еремеева М.В. Современное состояние и перспективы использования ангиогенеза в лечение ишемичес- кой болезни сердца. Грудная и сердечно-сосудистая хирургия. 2000: 2: 57–61. 5. Duan J., Murohara T. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia. Circulation. 2000; 102: III- 370–6. 6. Bauters C., Asahara T., Zheng L.P. et al. Physiological assessment of augment vascularity induce by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 1994; 267 (4, part 2): H1263–71. 7. Bauters C., Asahara T. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 1995; 21: 314–24. 8. Takeshita S., Zheng L.P., Brogi E. et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 1994; 93: 662–70. 9. Takeshita S., Pu L.Q., Stein L.A. et al. Intramuscular administration of vascular endothelial growth factor induced dose-dependent collateral artery augmentation in a rabbit model of persistent limb ischemia. Circulation. 1994; 90 (5, suppl. 2): II228–34. 10. Fuchs S., Baffour R., Zhou Y.F. et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pig with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 2001; 37: 1726–32. 11. Hamano K., Li T.-Sh., Kobayashi T. et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery. 2001; 130: 44–54. 12. Satoshi S., Murohara T., Ikeda H. et al. Augmentation of postnatal bone marrow transplantation. Circulation. 2001; 103: 897–903. 13. Baumgartner I., Pieczek А., Manor O. et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998; 97: 1114–23. 14. Folkman J. Terapeutic angiogenesis in ischemic limb. Circulation. 1998; 97: 1108–10. 15. Tateishi-Yuyama Е., Matsubara H., Murohara T. et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet. 2002; 360: 427–35.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery